Dynamic monitoring of PD‐L1 and Ki67 in circulating tumor cells of metastatic non‐small cell lung cancer patients treated with pembrolizumabMaria Spiliotaki(University of Cyprus), Haris Charalambous(Bank of Cyprus Oncology Center)Molecular OncologySeptember 30, 202210.1002/1878-0261.13317Cited by 35SaveCiteExport RISWatch citationsRelated PapersExpression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes|Molecular Oncology|2017|17